ArticleBlood cancer journal2025

EBV+ polymorphic B-cell lymphoproliferative disorder, NOS: a single-center study of a newly recognized pathologic entity.

Suheil Albert Atallah-Yunes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.